LakeShore Biopharma (LSB) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
LakeShore Biopharma has announced an extraordinary general meeting (EGM) for shareholders on September 27, 2024, to vote on resolutions aimed at regaining compliance with Nasdaq’s minimum bid price requirement, including a proposed share consolidation. The meeting will be held virtually via Zoom, with detailed instructions provided for shareholders to join. The board of directors fully endorses the proposed actions and encourages shareholder participation and approval.
For further insights into LSB stock, check out TipRanks’ Stock Analysis page.